Wealth Enhancement Advisory Services, LLC Atai Life Sciences N.V. Transaction History
Wealth Enhancement Advisory Services, LLC
- $65.4 Billion
- Q4 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 57,232 shares of ATAI stock, worth $228,928. This represents 0.0% of its overall portfolio holdings.
Number of Shares
57,232
Previous 109,787
47.87%
Holding current value
$228,928
Previous $580,000
60.69%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ATAI
# of Institutions
146Shares Held
45.9MCall Options Held
1.88MPut Options Held
543K-
Ubs Group Ag7.68MShares$30.7 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.43MShares$21.7 Million0.05% of portfolio
-
Morgan Stanley New York, NY4.82MShares$19.3 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.58MShares$10.3 Million0.0% of portfolio
-
Ally Bridge Group (Ny) LLC New York, NY2.29MShares$9.15 Million12.47% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $664M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...